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Introduction of a biotinylated monophosphine palladium complex within streptavidin aﬀords an
enantioselective artiﬁcial Suzukiase. Site-directed mutagenesis allowed the optimization of the activity
and the enantioselectivity of this artiﬁcial metalloenzyme. A variety of atropisomeric biaryls were
produced in good yields and up to 90% ee. The hybrid catalyst described herein shows comparable TOF
to the previous aqueous-asymmetric Suzuki catalysts, and excellent stability under the reaction
conditions to realize higher TON through longer reaction time.Introduction
The palladium-catalyzed Suzuki–Miyaura cross-coupling reac-
tion (SMC hereaer) of organic halides with boronic acids is one
of the most versatile methods for the synthesis of biaryls.1–3
Such structural motifs are present in numerous agrochemicals,
natural products, pharmaceuticals, and polymers.4,5 For this
purpose, the SMC has been widely studied.6–11 More recently,
the SMC has found applications in the context of chemical
biology. Indeed, both reactants and products can be regarded as
bio-orthogonal.12–18 In this promising context however, high
catalyst loadings are routinely required with reactions per-
formed in a biological environment.12,13,15,17,19–27
In stark contrast to the SMC, Nature relies on very diﬀerent
mechanisms to install (atropisomeric) Caryl–Caryl bonds.28Despite
numerous reports on asymmetric SMC in organic media,6–8,29
only two reports describe enantioselective SMC in water.30,31
Uozumi reported on an heterogeneous SMC in water requiring
a high catalyst loading (TON < 10, 94% ee at 80 C).30 More
recently, Ku¨ndig et al. reported an asymmetric SMC in an water–
organic solvent mixture (TON ¼ 17, up to 80% ee) at room
temperature.31 To complement these eﬀorts, we speculated that,
thanks to their well-dened second coordination sphere, arti-
cial metalloenzymes (ArMs hereaer) may oﬀer a propitious
environment to engineer an asymmetric “Suzukiase”-that is, an
enzyme that catalyzes the SMC. ArMs result from the incorpo-
ration of an abiotic cofactor within a macromolecule (protein or
oligonucleotide).13,14,32–35 In this context, Ueno and coworkers
anchored a palladium moiety within a ferritin container to yieldBasel, Spitalstrasse 51, 4056 Basel,
ch
5232 Villigen PSI, Switzerland
tion (ESI) available. See DOI:
hemistry 2016an articial Suzukiase. The resulting articial Suzukiase however
did not outperform the free cofactor (no enantioselectivity,
turnover frequency TOF: 3500 h1, no TON mentioned).13
Inspired by a seminal contribution by Whitesides in 1978,32 we
report herein our eﬀort to engineer an asymmetric articial
Suzukiase based on the biotin–streptavidin technology.Results and discussion
With the aim of identifying suitable cross-coupling reaction
conditions, we evaluated ve diﬀerent biotinylated catalyst
precursors 1–5 in the presence of either avidin or streptavidin
(Avi and Sav hereaer). For this purpose, the reaction of 1-
iodonaphthalene 6c with 2-methoxy-1-naphthaleneboronic acid
7c was selected as a model system (Scheme 1). Initial experi-
ments revealed that protonolysis of the boronic acid led to
modest cross-coupling yields. Systematic variation of the base,
pH, and organic co-solvent led to the identication of suitable
reaction conditions: sodium hydroxide in DMSO : water (1 : 9)
proved to be particularly eﬀective in preventing protonolysis.
However, competing deboronation required the use of excess
boronic acid (1.5 equivalents vs. aryl halide) to achieve full
conversion. Gel electrophoresis of the reaction mixture revealed
that Sav remained largely tetrameric and active toward biotin
binding even aer an SMC performed at 50 C (see ESI Fig. S3†).
Having identied suitable reaction conditions, we screened
biotinylated phosphine- and NHC ligands 1–5 combined with
WT (strept)avidin (Table 1). This screening led to the identi-
cation of complexes 1, 2, and 3 as the most promising catalysts
in combination with WT Sav. Despite the structural similarity
between avidin and streptavidin, the result obtained with avidin
was inferior to those obtained with Sav. We thus focused on Sav
for further optimization studies. Past experience with other
ArMs based on the biotin–streptavidin technology suggest that
mutations at positions S112 and K121 (which lie closest to theChem. Sci., 2016, 7, 673–677 | 673
Scheme 1 Biotinylated cofactors 1–5 tested in the presence of (strept)
avidin as artiﬁcial Suzukiase for the synthesis of enantioenriched 2-
methoxy-1,10-binaphthyl 8b.
Table 1 Identiﬁcation of the most suitable ligand for the synthesis of
2-methoxy-1,10-binaphthyl 8ba
Entry Complex Protein eeb [%] TON
1 1 WT Sav 58 (R) 78
2 2 WT Sav 10 (S) 73
3 3 WT Sav 42 (R) 45
4 4 WT Sav 6 (R) 8
5 5 WT Sav rac <5
6 1 WT Avi 3 (R) 10
a Reactions were carried out with 50 mM substrate in a total reaction
volume 0.2 mL using 1 mol% complex 1–5 (see ESI for experimental
details). b ee value determined by HPLC on a chiral stationary phase;
absolute conguration assigned by comparison with literature data.
WT ¼ wild-type, Sav ¼ streptavidin, Avi ¼ avidin. All reactions were
performed in duplicate: Dee ¼ 1%, Dconv. ¼ 5%.
Fig. 1 Fingerprint display of the results of the chemogenetic optimi-
zation for the synthesis of 2-methoxy-1,10-binaphthyl 8b. The size of
the circles is proportional to the conversion, and the color codes the
enantiomeric excess. Numerical results are collected Table 2 and in
Table S1 (ESI†).
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View Article Onlinebiotinylated metal cofactor) oﬀer a versatile means to rapidly
optimize the ArM's performance. Complexes 1–3 were thus
screened with a small library of Sav mutants. The results of the
chemogenetic optimization for the synthesis of 2-methoxy-1,10-
binaphthyl 8b are displayed as a ngerprint in Fig. 1, and
selected results are collected in Table 2.
From these data, the following features emerge:
(a) Compared to the free cofactor, higher conversions are
observed with the articial Suzukiase. This demonstrates that
the Sav host protein exerts a benecial inuence on both the
activity (i.e. protein accelerated catalysis)36 and the selectivity.
(b) The electron-donating properties and bulkiness of the
phosphine play a key role in determining the activity of the
corresponding articial Suzukiase. Accordingly, the (t-Bu)2P-
bearing catalysts outperform the (Ph)2P-systems. Strikingly,
both ligands 1 and 3 (Table 2, entries 10–13) show similar
activity in case of S112M and S112A mutants.674 | Chem. Sci., 2016, 7, 673–677(c) The enantioenriched nature of the cross-coupled product
8b strongly supports the hypothesis that the SMC is indeed
catalysed by a homogeneous protein-embedded Pd-cofactor
rather than Pd-nanoparticles.12,25,26,37
(d) Varying the spacer between the biotin anchor and the P(t-
Bu)2 from ethyl to propyl aﬀords opposite enantiomers of biaryl
8b for a given Sav mutant. The best ees in favour of (S)-8b were
obtained with 2$Sav K121A and 2$Sav S112M (Table 2, entries 8
and 9). These ndings illustrate the versatility of chemogenetic
optimization strategy: upon varying the length of the spacer the
Pd-moiety experiences a very diﬀerent second coordination
sphere environment which is reected in the enantioselectivity.
Having identied 1$Sav K121E as a promising rst genera-
tion Suzukiase (Table 2, entry 3), we screened double mutants
bearing a glutamate at position 121 (Fig. 1 and Table 2, entries
14–21):
(a) The double mutant 1$Sav S112A–K121E (Table 2, entry 20)
gives better ee and TON than the single mutant Sav S112A
(Table 2, entry 13). Likewise, 1$Sav S112Y–K121E gave theThis journal is © The Royal Society of Chemistry 2016
Table 2 Selected results for genetic optimization of the artiﬁcial
Suzukiase for the synthesis of 2-methoxy-1,10-binaphthyl 8b
Entry Temp [C] Complex Protein ee [%] TON
1 RT 1 — rac 20
2 RT 1 WT 58 (R) 78
3 RT 1 K121E 76 (R) 50
4 RT 1 K121D 34 (R) 7
5 RT 1 K121Q 74 (R) 20
6 RT 1 K121M 67 (R) 59
7 RT 1 K121F 67 (R) 38
8 RT 2 K121A 47 (S) 32
9 RT 2 S112M 44 (S) 53
10 RT 3 S112M 38 (R) 78
11 RT 3 S112A 36 (R) 52
12 RT 1 S112M 14 (S) 58
13 RT 1 S112A 60 (R) 58
14 RT 1 N118K–K121E 74 (R) 73
15 RT 1 N118S–K121E 76 (R) 79
16 RT 1 N118E–K121E 76 (R) 75
17 RT 1 N118L–K121E 72 (R) 86
18 RT 1 S112W–K121E 76 (R) 64
19 RT 1 S112N–K121E 69 (R) 61
20 RT 1 S112A–K121E 70 (R) 80
21 RT 1 S112Y–K121E 80 (R) 90
22 RT 1 S112Y–K121E 80 (R) 160a
23 16 1 S112Y–K121E 84 (R) 50
24 4 1 S112Y–K121E 86 (R) 50b
25 4 1 S112Y–K121E 90 (R) 50c
a 0.50 mol% catalyst loading, 0.25 mol% Sav (tetramer) loading. b 0.50
mol% catalyst loading, 0.25 mol% Sav (tetramer) loading, aer 7 days.
c Preparative scale (100 mmol). All reactions were performed in
duplicate: Dee ¼ 1%, Dconv. ¼ 5%.
Fig. 2 Substrates tested for the asymmetric Suzuki–Miyaura cross-
coupling reaction catalysed by 1$S112Y–K121E.
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View Article Onlinehighest turnover with good ee (Table 2, entry 22). This nding
highlights the non-additive nature of multiple mutations.38,39
Decreasing the temperature to 4 C leads to an improvement in
enantioselectivity (86% ee, Table 2, entry 24) albeit at the cost of
a slower rate.
(b) Increasing the ratio of complex 1 vs. Sav tetramer (S112Y–
K121E mutant) from one to four leads to a gradual erosion of
enantioselectivity (from 80 to 69% ee, see Table S4, ESI†). This
suggests that an empty biotin binding site adjacent to a complex
1 within Sav is favorable for selectivity.
(c) On a preparative scale, up to 90% ee (R)-8b, were obtained
using 0.50 mol% catalyst loading and 0.25 mol% Sav (tetramer)
loading at 4 C (Table 2, entry 25).
(d) Upon decreasing the catalyst loading, a TON¼ 160 (TOF <
10 h1) is obtained with a constant ee (Table 2 entries 21–22).
This TON compares favourably with the other aqueous asym-
metric homogeneous SMC catalysts (TON ¼ 10,30 and 17
respectively31) compared to the achiral Suzukiase reported by
Ueno13 however, the TOF is signicantly lower (compare TOF
3500 h1 vs. <10 h1).
The articial Suzukiase performed well on a range of
hydrophobic substrates, leading to the following observations
(Table 3, Fig. 2):
(a) The nature of the aryl halide does not inuence the
enantioselectivity but to lower conversions on going from
iodide to bromide to chloride 6a–c (Table 3, entries 6–8).This journal is © The Royal Society of Chemistry 2016(b) Substitution of the methoxy group by either a methyl and
ethoxy group on the arylboronic acid (compare 7c to 7b and 7d)
leads lower enantioselectivities (Table 3, entries 7, 10 and 12).
Depending on the nature of the ortho-substituent of the aryl
moiety, the CIP priorities are inverted, yielding the opposite
absolute conguration (e.g. compare 8b and 8d) for the same
spacial arrangement. With the exception of the biphenyl-
binaphthyl 8h, all SMC products aﬀord the same spacial
arrangement using 1$S112Y–K121E Sav. We speculate that upon
binding to the palladium cofactor, the bulky biphenyl group 7h
forces the catalyst into a diﬀerent second coordination sphere
environment, leading to the opposite enantiomer (and spacial
arrangement) of the coupled product.
(c) The system aﬀords the highest enantioselectivity for
binaphthyls or naphthyl-o-biphenyl products (albeit with the
opposite chirality) in the presence of one smaller coupling
partner, (e.g. 6h), the enantioselectivity is signicantly lower.X-ray structure
To gain structural insight on the second coordination sphere
around the Pd moiety, crystals of Sav S112Y–K121E were grownChem. Sci., 2016, 7, 673–677 | 675
Fig. 3 Close-up view of the structure of the artiﬁcial Suzukiase
1$S112Y–K121E Sav (pdb code: 5CSE). The solvent-excluded surfaces
of two symmetry-related Sav monomers are highlighted in grey and
magenta respectively. The biotinylated Pd-cofactor 1 and the mutated
residues S112Y and K121E are displayed as stick. No electron density for
the cinnamyl-moiety (turquoise) could be detected and was thus
modelled, minimizing steric-clashes.
Table 3 Selected results for the SMC with 1$S112Y–K121E Sav on
a variety of substratesa
Entry ArX Ar0B(OH)2 Product Temp [C] ee [%] TON
1 6d 7a 8b RT 80 (R) 32
2 6g 7e 8d 50 80 (S) 20
3 6d 7e 8e 50 74 (R) 61
4 6g 7f 8f 50 64 (S) 50
5 6g 7h 8h RT 65 (R) 29
6 6a 7c 8b RT 80 (R) 7
7 6b 7c 8b RT 80 (R) 63
8 6c 7c 8b RT 80 (R) 80
9 6f 7a 8a RT 69 (S) 64
10 6b 7b 8a 50 76 (S) 81
11 6b 7b 8a 4 87 (S) 8b
12 6c 7d 8c RT 68 (R) 88
13 6e 7a 8b RT 77 (R) 55
14 6h 7c 8g RT 35 (R) 80
a All reactions were performed in duplicate:Dee¼1%,Dconv.¼5%.
The absolute conguration of the product were assigned according to
ref. 8. See ESI for experimental details. b Aer 7 days.
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View Article Onlineand soaked with a solution of 1 in DMSO (for details, see ESI†).
The resulting crystals were subjected to X-ray diﬀraction at the
beamline X06DA at the Swiss Light Source. In the resulting
structure of complex 1$S112Y–K121E Sav, there is strong
residual electron density in the 2Fo  Fc diﬀerence map in the
biotin-binding vestibule. The Pd atom was unambiguously
assigned as a strong peak in the diﬀerence map (12s) with
a corresponding peak in the anomalous diﬀerence map (8s).
The density map clearly highlights the presence of the phos-
phine ligand, the palladium, and the chloride (see ESI Fig. S5†).
However, the cinnamyl ligand could not be resolved, likely due
to disorder caused by ligand uxionality. The amide linker
exhibits two H-bonding interactions with the protein backbone:
the amide nitrogen exhibits an H-bonding interaction with the
side-chain of S88, and the carbonyl oxygen exhibits an H-
bonding interaction with the backbone nitrogen of N49. The
palladium atoms of two symmetry related-cofactors (face-to-
face) are separated by 11.7 A˚. The palladium was found in the
vicinity of the O atoms of S112Y and K121E (Pd/O distance 6.4
A˚ and 7.1 A˚ respectively). The average B-factor of Pd is 36.10,
suggesting that the complex may be uxional or located in
a shallow energy minimum (Fig. 3).
In the synthesis of chiral biaryls by the SMC, enantiose-
lectivity is dictated by the conformation of the Pd intermediate
just prior to reductive elimination.40,43 In previous DFT studies
of enantioselective reductive eliminations in the SMC, it was
shown that weak interactions between substrates and
substrate–ligand interactions were largely responsible for
biasing certain conformations and thus leading to enantioin-
duction.6,40,44 By contrast, in the 1$Sav system, it is more likely676 | Chem. Sci., 2016, 7, 673–677that the origin of the enantioselectivity observed is from the
outer-sphere ligand eﬀect of the protein. Inspection of the X-ray
structure of the active site of 1$S112Y–K121E shows that the Pd-
phosphine ligand is eﬀectively “locked” into place by the steric
environment of the Sav protein, which is evidenced by the
discrete atomic position of the Pd and P and their relatively low
B-factors despite proximity to the solvent pocket. The restricted
conformational space around the Pd atom limits certain
conformations. The nearby mutated residues play an additional
role. In particular, mutation of S112 to the larger tyrosine
provides a signicant steric barrier on the lower face of the Pd
atom and is most likely responsible for the modest improve-
ment in enantioselectivity upon mutation. Furthermore, the
conformation of Y112 is eﬀectively locked in place by an H-
bonding interaction of the sidechain oxygen with the backbone
carbonyl of E121 (distance 2.88 A˚), which would not be the case
with the similarly large S112W mutation (Table 2, entry 18).
Further X-ray studies of 1$Sav with various mutations are
currently underway.
It should be emphasized however that, while the X-ray
structure sheds light on the position of the biotinylated catalyst
precursor, we cannot exclude that the loaded catalyst, bearing
the two bulky aromatic coupling partners, adopts a diﬀerent
position within the biotin-binding vestibule. As demonstrated
recently for an articial imine reductase, QM-MM studies may
shed light on the enantioselection mechanism and the precise
geometry of the transition state.41 In this context, reducing the
cofactor exibility by introducing stabilizing interactions with
the protein has proven useful.42Conclusions
In summary, incorporation of an electron-rich phosphino–
palladium moiety within Sav aﬀords an articial Suzukiase for
the synthesis of enantioenriched binaphthyls (up to 90% ee and
50 TONs for 2-methoxy-binaphthyl 8b). While it is straightfor-
ward to identify aminoacids close to the cofactor, it is remainsThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineextremely challenging to predict or rationalize why a given
mutation leads to an improvement in catalytic performance.
The chemogenetic optimization strategy allows to address this
challenge with a limited eﬀort: combining a small library of m
mutants with a small library of n biotinylated ligands aﬀords an
m$n diversity matrix. Current eﬀorts are aimed at performing
catalytic asymmetric SMC with articial Suzukiases in vivo.
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